Abstract:Introduction: Vascularized composite allotransplantation (VCA) is the transplantation of multiple tissue types as a solution for devastating injuries. Despite the highly encouraging functional outcomes of VCA, the consequences of long-term immunosuppression remain the main obstacle in its application. In this review, we provide researchers and surgeons with a summary of the latest advances in the field of cell-based therapies for VCA tolerance. Methods: Four electronic databases were searched: PubMed, Scopus, Cumulative Index to Nursing and Allied Health Literature , and Web of Science. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis as the basis of our organization. Results: Hematopoietic stem cells prolonged VCA survival. A combination of immature dendritic cells and tacrolimus was superior to tacrolimus alone. T cell Ig domain and mucin domain modified mature dendritic cells increased VCA tolerance. Bone marrow-derived mesenchymal stem cells prolonged survival of VCAs. A combination of adipose-derived mesenchymal stem cells, cytotoxic T-lymphocyte antigen 4 immunoglobulin, and antilymphocyte serum significantly improved VCA tolerance. Ex-vivo allotransplant perfusion with recipient's bone marrow-derived mesenchymal stem cells increased VCA survival. Recipient's adipose-derived mesenchymal stem cells and systemic immunosuppression prolonged VCA survival more than any of those agents alone. Additionally, a combination of peripheral blood mononuclear cells shortly incubated in mitomycin and cyclosporine significantly improved VCA survival. Finally, a combination of donor recipient chimeric cells, anti-αβ-T cell receptor (TCR), and cyclosporine significantly prolonged VCA tolerance. Conclusions: Evidence from animal studies shows that cell-based therapies can prolong survival of VCAs. However, there remain many obstacles for these therapies, and they require rigorous clinical research given the rarity of the subjects and the complexity of the therapies. The major limitations of cell-based therapies include the need for conditioning with immunosuppressive drugs and radiation, causing significant toxicity. Safety concerns also persist as most research is on animal models. While completely replacing traditional immunosuppression with cell-based methods is unlikely soon, these therapies could reduce the need for high doses of immunosuppressants and improve VCA tolerance.

Stem cell-based approaches to enhance nerve regeneration and improve functional outcomes in vascularized composite allotransplantation

Cell therapy in vascularized composite allotransplantation

Cellular activation pathways and interaction networks in vascularized composite allotransplantation

Advances and Future Applications of Augmented Peripheral Nerve Regeneration

Cell-Based Therapies Induce Tolerance of Vascularized Composite Allotransplants: A Systematic Review

Cell therapies and its derivatives as immunomodulators in vascularized composite allotransplantation

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Advances in the repair of segmental nerve injuries and trends in reconstruction

The current state of tolerance induction in vascularized composite allotransplantation

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Combinatorial strategies for cell transplantation in traumatic spinal cord injury

Challenges in advancing Schwann cell transplantation for spinal cord injury repair

Biomaterial-Based Schwann Cell Transplantation and Schwann Cell-Derived Biomaterials for Nerve Regeneration

Ethical challenges in vascularized composite allotransplantation of the lower extremity: lessons learned from hand transplantation and implications for the future

Biohacking Nerve Repair: Novel Biomaterials, Local Drug Delivery, Electrical Stimulation, and Allografts to Aid Surgical Repair

Current Challenges for the Advancement of Neural Stem Cell Biology and Transplantation Research

Stem‐cell–based therapies to enhance peripheral nerve regeneration

Are They a Promising Immunomodulatory Approach for Organ and Vascularized Composite Allotransplantation?

Multipotent vascular stem cells contribute to neurovascular regeneration of peripheral nerve

Innovations in Peripheral Nerve Regeneration

Advances of Schwann cells in peripheral nerve regeneration: From mechanism to cell therapy